UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study

The oncologist (Dayton, Ohio), 2020-04, Vol.25 (4), p.e668-e674

2020

Volltextzugriff (PDF)

Olaparib for BRCA mutant pancreas cancer: Should the POLO trial change clinical practice?

Cancer, 2020-09, Vol.126 (18), p.4087-4088

2020

Volltextzugriff (PDF)

Integration of CD4+ T cells and molecular subtype predicts benefit from PD‐L1 blockade in muscle‐invasive bladder cancer

Cancer science, 2024-04, Vol.115 (4), p.1306-1316

2024

Volltextzugriff (PDF)

Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy

IUBMB life, 2018-03, Vol.70 (3), p.183-191

2018

Volltextzugriff (PDF)

Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy

International journal of cancer, 2024-04, Vol.154 (8), p.1474-1483

2024

Volltextzugriff (PDF)

TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma

The Journal of pathology, 2024-06, Vol.263 (2), p.139-149

2024

Volltextzugriff (PDF)

BRCA1/2 reversion mutations in a pan‐cancer cohort

Cancer science, 2024-02, Vol.115 (2), p.635-647

2024

Volltextzugriff (PDF)

The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients

Journal of cachexia, sarcopenia and muscle, 2022-06, Vol.13 (3), p.1554-1564

2022

Volltextzugriff (PDF)

REV7 is involved in outcomes of platinum‐based chemotherapy in pancreatic cancer by controlling the DNA damage response

Cancer science, 2024-02, Vol.115 (2), p.660-671

2024

Volltextzugriff (PDF)

Chemotherapy Toxicity in BRCA Mutation Carriers Undergoing First‐Line Platinum‐Based Chemotherapy

The oncologist (Dayton, Ohio), 2019-12, Vol.24 (12), p.e1471-e1475

2019

Volltextzugriff (PDF)

Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab

International journal of urology, 2023-09, Vol.30 (9), p.730-736

2023

Volltextzugriff (PDF)

Age‐related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum‐based chemotherapy

Clinical and experimental pharmacology & physiology, 2017-12, Vol.44 (S1), p.21-29

2017

Volltextzugriff (PDF)

Targeting lipid droplet lysophosphatidylcholine for cisplatin chemotherapy

Journal of cellular and molecular medicine, 2020-07, Vol.24 (13), p.7187-7200

2020

Volltextzugriff (PDF)

Insights into platinum-induced peripheral neuropathy-current perspective

Neural regeneration research, 2020-09, Vol.15 (9), p.1623-1630

2020

Volltextzugriff (PDF)

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy

Cancer science, 2021-01, Vol.112 (1), p.359-368

2021

Volltextzugriff (PDF)

Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study

Thoracic cancer, 2020-11, Vol.11 (11), p.3317-3325

2020

Volltextzugriff (PDF)

Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum‐based doublet chemotherapy

The journal of gene medicine, 2023-01, Vol.25 (1), p.e3460-n/a

2023

Volltextzugriff (PDF)

Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum‐Based Chemotherapy in Patients With Non‐Small Cell Lung Cancer: A Network Meta‐Analysis

Journal of cellular biochemistry, 2017-12, Vol.118 (12), p.4782-4791

2017

Volltextzugriff (PDF)

DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study

Translational lung cancer research, 2022-12, Vol.11 (12), p.2539-2566

2022

Volltextzugriff (PDF)

POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1

Cancer medicine (Malden, MA), 2024-02, Vol.13 (4), p.e6962-n/a

2024

Volltextzugriff (PDF)

An ERCC4 regulatory variant predicts grade‐3 or ‐4 toxicities in patients with advanced non‐small cell lung cancer treated by platinum‐based therapy

International journal of cancer, 2018-03, Vol.142 (6), p.1218-1229

2018

Volltextzugriff (PDF)

DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients

Diagnostic pathology, 2023-11, Vol.18 (1), p.119-11, Article 119

2023

Volltextzugriff (PDF)

A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation

Pathology international, 2019-12, Vol.69 (12), p.715-720

2019

Volltextzugriff (PDF)

A diagnostic microdosing approach to investigate platinum sensitivity in non‐small cell lung cancer

International journal of cancer, 2017-08, Vol.141 (3), p.604-613

2017

Volltextzugriff (PDF)

Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the literature

Thoracic cancer, 2023-06, Vol.14 (17), p.1589-1596

2023

Volltextzugriff (PDF)

1 – 25 von 642

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(578)
Mit Volltextzugriff
(570)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(572)
Life Sciences & Biomedicine
(565)
Platinum-Based Chemotherapy
(444)
Humans
(372)
Oncology
(367)
Chemotherapy
(286)
Female
(249)
Middle Aged
(207)
Aged
(172)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(165)
Male
(157)
Adult
(154)
Lung Cancer
(145)
Lung Neoplasms - Drug Therapy
(145)
Tumors
(123)
Platinum
(120)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(118)
Cancer Therapies
(112)
Cancer
(105)
Prognosis
(105)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gynecologic Oncology
(21)
Lung Cancer
(21)
Anticancer Research
(15)
Annals Of Oncology
(13)
Frontiers In Oncology
(13)
International Journal Of Molecular Sciences
(13)
Cancers
(12)
Clinical Lung Cancer
(11)
International Journal Of Gynecological Cancer
(11)
Medicine
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study

Olaparib for BRCA mutant pancreas cancer: Should the POLO trial change clinical practice?

Integration of CD4+ T cells and molecular subtype predicts benefit from PD‐L1 blockade in muscle‐invasive bladder cancer

Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy

Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy

TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma

BRCA1/2 reversion mutations in a pan‐cancer cohort

The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients

REV7 is involved in outcomes of platinum‐based chemotherapy in pancreatic cancer by controlling the DNA damage response

Chemotherapy Toxicity in BRCA Mutation Carriers Undergoing First‐Line Platinum‐Based Chemotherapy

Significance of second progression‐free survival in patients with advanced urothelial cancer who received platinum‐based combination chemotherapy followed by pembrolizumab

Age‐related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum‐based chemotherapy

Targeting lipid droplet lysophosphatidylcholine for cisplatin chemotherapy

Insights into platinum-induced peripheral neuropathy-current perspective

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy

Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study

Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum‐based doublet chemotherapy

Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum‐Based Chemotherapy in Patients With Non‐Small Cell Lung Cancer: A Network Meta‐Analysis

DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study

POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1

An ERCC4 regulatory variant predicts grade‐3 or ‐4 toxicities in patients with advanced non‐small cell lung cancer treated by platinum‐based therapy

DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients

A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation

A diagnostic microdosing approach to investigate platinum sensitivity in non‐small cell lung cancer

Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the literature

Suchergebnisse filtern